SCHEDULE: Millennium Entities Disclose Over 5% Passive Stake in AngioDynamics

Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly disclosed beneficial ownership exceeding 5% of AngioDynamics, Inc.'s common stock.

Summary

• Integrated Core Strategies (US) LLC reported beneficial ownership of 2,124,268 shares, representing 5.2% of AngioDynamics, Inc. common stock.
• Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander each reported beneficial ownership of 2,145,888 shares, representing 5.3% of AngioDynamics, Inc. common stock.
• The beneficial ownership is held with shared voting and shared dispositive power by the reporting persons.
• The filing is a Schedule 13G, indicating a passive investment purpose, not for changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
• The event requiring this filing occurred on July 16, 2025, with the filing signed on July 21, 2025.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of beneficial ownership, indicating a neutral sentiment regarding the issuer's performance, though the presence of institutional investors can be seen as a positive signal.

Positives

• Disclosure of significant beneficial ownership by multiple Millennium entities and Israel A. Englander, indicating institutional interest in AngioDynamics, Inc. common stock.

Negatives

• The filing does not contain information that would be considered negative regarding AngioDynamics, Inc.'s operations or financial performance.

Risks

• The filing does not detail specific risks related to AngioDynamics, Inc.'s business operations or financial health.

Future Outlook

The filing is a disclosure of current beneficial ownership and does not provide any forward-looking statements or guidance regarding AngioDynamics, Inc.'s future performance or strategic outlook.

Industry Context

This filing is a standard disclosure of a significant passive ownership stake by institutional investors in a publicly traded company. It does not provide specific insights into broader industry trends or competitive landscape beyond the fact of investment in AngioDynamics, Inc.

Stakeholder Impact

• Shareholders: Disclosure of significant institutional ownership may influence investor perception and potentially share price due to increased institutional interest.

Key Dates

Keywords

AngioDynamics, Millennium Management, Integrated Core Strategies, Israel A. Englander, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investment, Passive Stake